Search criteria | ||||
Assessing the Outcomes for Orphan Status or Accelerated Assessment EMA Approved Medicines: A Comparison of Health Technology Assessment in Denmark, Finland, Norway and Sweden | ||||
Falla, Edel; Pitcher, Ashley; Acs, Annabel; Heller, Vincent; Zhang, Rongrong | ||||
IQVIA, Real-World Insights, London, LON, UK IQVIA, Real-World Insights, Copenhagen, Denmark IQVIA, Real-World Insights, Copenhagen, Denmark IQVIA, Real-World Insights, Solna, AB, Sweden IQVIA, Real-World Insights, Stockholm, Sweden | ||||
ISPOR Europe 2019, November 5, 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Denmark, Finland, Nordic, Norway, Sweden | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)34089-6/fulltext?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1098301519340896%3Fshowall%3Dtrue#%20 | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment | 2019 | English | , Review | |
MULTI-NATIONAL NORDIC PHARMACOEPIDEMIOLOGIC STUDIES: OPPORTUNITIES AND CHALLENGES | ||||
Svanström, Henrik [ 1 ]; Trojcakova, Iveta [ 1 ]; Pitcher, Ashley [ 1 ] | ||||
IQVIA, Copenhagen, Denmark | ||||
, Abstract | ||||
, Nordic | ||||
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S1098301519343153?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Public Health | 2019 | English | , Database Study, Epidemiological study, Longitudinal study, Observational study, Survey research | |
MULTI-NATIONAL NORDIC PHARMACOEPIDEMIOLOGIC STUDIES: OPPORTUNITIES AND CHALLENGES | ||||
H.SvanströmI.TrojčákováA.Pitcher | ||||
IQVIA, Copenhagen, Denmark | ||||
Journal: VALUE IN HEALTH Volume: 22 Pages: S768-S768 Supplement: 3 |
||||
, Abstract | ||||
, Nordic | ||||
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S1098301519343153?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Public Health | 2019 | English | , Population Based Study | |
Epidemiology of heart failure and trends in diagnostic work-up: a retrospective, population-based cohort study in Sweden | ||||
Lindmark K, Boman K, Olofsson M, Törnblom M, Levine A, Castelo-Branco A, Schlienger R, Wirta SB, Stålhammar J, Wikström G | ||||
Real-World & Analytics Solutions, IQVIA, Solna, Sweden | ||||
Clinical Epidemiology |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: https://www.dovepress.com/articles.php?article_id=44704 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2019 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis | |
Use of subcutaneous and intravenous trastuzumab: real-world experience from three hospitals in Sweden. | ||||
Valachis A, Sundqvist M, Carlsson L, Li B, Chiesa F, Uhde M, Sanglier T | ||||
Department of Oncology, Faculty of Medicine & Health, ?rebro University, SE 70182 ?rebro, Sweden (Valachis) AND Real World & Analytic Solutions (RWAS), IQVIA, Stockholm, Sweden (Milica Uhde) | ||||
Future Oncol. 2019 Aug;15(23):2733-2741. doi: 10.2217/fon-2019-0160. Epub 2019 Jul 15. |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31306041 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Clinical setting: hospital, Epidemiological study, Retrospective cohort analysis | |
Pregnancy and Infant Outcomes with Interferon Beta: Data from the European Interferon Beta Pregnancy Registry and MS Pregnancy study conducted in Finland and Sweden | ||||
"Kerstin Hellwig*, Yvonne Geissbuehler2, Meritxell Sabidó3, Catrinel Popescu4, Alessandra Adamo5, Joachim Klinger6, Peter Huppke7, Asher Ornoy8, Pasi Korhonen9, Kjell-Morten Myhr10, Scott Montgomery11, Sarah Burkill11, European Interferon Beta Pregnancy Study Group" | ||||
*Katholisches Klinikum Bochum, St Josef-Hospital Universitatsklinikum, Bochum, Germany; 9StatFinn & EPID Research, Espoo, Finland | ||||
AAN, Philadelphia, USA, 4-10 May 2019 |
||||
, Oral presentation | ||||
, Europe, Finland, Nordic, Sweden | ||||
Abstract: https://n.neurology.org/content/92/15_Supplement/S49.005 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2019 | English | , Epidemiological study, Population Based Study | |
Prevalence of infant outcomes at birth after exposure to interferon beta prior to or during pregnancy: A register-based cohort study in Finland and Sweden among women with MS | ||||
Pia Vattulainen1, Sarah Burkill2, Yvonne Geissbuehler3, Meritxell Sabidó4, Catrinel Popescu5, Kiliana Suzart-Woischnik6, Kjell-Morten Myhr7, Scott Montgomery2,8, Pasi Korhonen1 the European Interferon Beta Pregnancy Study Group and the Nordic MS Pregnancy & Interferon Beta study group | ||||
1StatFinn-EPID Research, Espoo, Finland | ||||
ECTRIMS, Stockholm, Sweden, 11-13 September, 2019 |
||||
, Poster | ||||
, Finland, Nordic, Sweden | ||||
Abstract: https://onlinelibrary.ectrims-congress.eu/ectrims/2019/stockholm/278346/pasi.korhonen.prevalence.of.infant.outcomes.at.birth.after.exposure.to.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3Dmontgomery | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2019 | English | , Epidemiological study, Population Based Study, Retrospective cohort analysis | |
CLUE: Consequences for life of children with in utero exposure to metformin in Finland | ||||
Kerstin Brand, Judith Schlachter, Emmanuelle Boutmy, Caroline Foch, Pasi Korhonen, Katja Hakkarainen, Jaak Sonajalg, Minna Vehkala, Laura Saarelainen | ||||
Merck KGaA: Kerstin Brand, Judith Schlachter, Emmanuelle Boutmy, Caroline Foch IQVIA (SF-EPID): Pasi Korhonen, Katja Hakkarainen, Jaak Sonajalg, Minna Vehkala, Laura Saarelainen | ||||
The International Diabetes Federation (IDF) Congress 2019 |
||||
, Oral presentation | ||||
, Finland, Nordic | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2019 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Observational study, Population Based Study, Public Health, Retrospective cohort analysis, Retrospective database analysis | |
Use of postmenopausal hormone therapy and risk of Alzheimer?s disease in Finland: nationwide case-control study | ||||
Savolainen-Peltonen H, Rahkola-Soisalo P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS. | ||||
EPID Research Oy, Espoo, Finland | ||||
BMJ |
||||
, Article | ||||
, Finland, Nordic | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402043/ | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2019 | English | , Epidemiological study, Retrospective database analysis | |
Observational evidence from patients diagnosed with chronic lymphocytic leukaemia (CLL) in Finland between 2005-2015 show improved survival over time. | ||||
Lindström V, Hakkarainen KM, Mehtälä J, Klement R, Leval A, Järvinen TM | ||||
VL: Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland. JM, KMH: StatFinn & EPID Research. AL, TMJ: Janssen-Cilag. | ||||
Eur J Haematol. 2019 Sep;103(3):190-199. doi: 10.1111/ejh.13273. |
||||
, Article | ||||
, Finland, Nordic | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31210368 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Clinical setting: hospital, Epidemiological study, Observational study, Retrospective cohort analysis | |
Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada | ||||
Sean Wharton1, Aiden Liu2, Arash Pakseresht2, Emil N?rtoft3, Christiane L. Haase3, Johanna Mancini4, G. Sarah Power5, Sarah Vanderlelie1, and Rebecca A. G. Christensen1 | ||||
1 Wharton Medical Clinic, Burlington, Canada. Correspondence: Sean Wharton (wharton@whartonmedicalclinic.com) 2 Novo Nordisk Canada Inc., Mississauga, Canada 3 Novo Nordisk A/S, S?borg, Denmark 4 IQVIA, Kirkland, Canada 5 IQVIA, Mississauga, Canada. | ||||
Obesity (Silver Spring). 2019 Jun;27(6):917-924. doi: 10.1002/oby.22462. Epub 2019 May 7. |
||||
, Article | ||||
, Canada, Nordic | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31062937 | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2019 | English | ||
Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR) | ||||
Larsson K, Ställberg B, Lisspers K, Telg G, Johansson G, Thuresson M, Janson C | ||||
Work Environment Toxicology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden | ||||
Respiratory Research (2018) 19:12 |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-018-0719-x | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2018 | English | , Clinical setting: Primary care, Epidemiological study, Observational study, Population Based Study | |
Prevalence, characteristics and management of frequently exacerbating asthma patients: an observational study in Sweden (PACEHR) | ||||
Janson C, Lisspers K, Ställberg B, Johansson G, Thuresson M, Telg G, Larsson K | ||||
Respiratory, Allergy and Sleep Research, Dept of Medical Sciences, Uppsala University, Uppsala, Sweden | ||||
European Respiratory Journal (2018) 52: 1701927 |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: http://erj.ersjournals.com/content/52/2/1701927 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2018 | English | , Clinical setting: Primary care, Epidemiological study, Observational study, Population Based Study | |
Total cost of health care resource utilization for asthma patients in Sweden with different exposures to oral corticosteroids | ||||
Janson C, Lisspers K, Ställberg B, Johansson G, Thuresson M, Telg G, Christensen H, Larsson K | ||||
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Sweden | ||||
Allergy. European Journal of Allergy and Clinical Immunology, Vol. 73, no Suppl.105, p. 529-529 |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: http://uu.diva-portal.org/smash/record.jsf?pid=diva2%3A1260079&dswid=-316 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2018 | English | , Clinical setting: Primary care, Cost analysis | |
Different patterns of second?line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study | ||||
Persson F, Bodegard J, Lahtela JT, Nyström T, Jørgensen ME, Jensen ML, Gulseth HL, Thuresson M, Hoti F, Nathanson D, Norhammar A, Birkeland KI, Eriksson JG, Eriksson JW | ||||
StatFinn & EPID Research, Espoo, Finland | ||||
Endocrinol Diabetes Metab. |
||||
, Article | ||||
, Denmark, Finland, Nordic, Norway, Sweden | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354817/ | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Population Based Study, Retrospective database analysis | |
#4018 Treatment patterns in patients (pts) with stage IIIB-IV non-small cell lung cancer (NSCLC) in Sweden: The SCAN-LEAF study | ||||
Simon Ekman,Maria Planck, Jens Benn Sørensen, Pia Horvat, Deborah Layton, Joseph Kim, Mats Rosenlund, Ariadna Juarez-Garcia, Melinda Daumont, Hazel C. Jacobs, Laure Lacoin, Odd Terje Brustugun | ||||
Department of Oncology, Karolinska University Hospital-Solna, Stockholm, Sweden; Division of Oncology and Pathology, Skane University Hospital-Lund, Lund, Sweden; Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Real-World Evidence Solutions, IQVIA, London, UK; Data Science, IQVIA, London, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Uxbridge, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Braine-L?Alleud, Belgium, Department of Oncology, Radiumhospitalet, Oslo, Norway | ||||
, Poster | ||||
, Nordic, UK | ||||
Condition | Year | Language | Analysis type | |
2018 | English | , Retrospective cohort analysis | ||
Cost-utility analysis of life-long prophylaxis with recombinant factor VIIIFc vs recombinant factor VIII for the management of severe hemophilia A in Sweden. | ||||
Henry N1, Jovanović J1, Schlueter M1, Kritikou P2, Wilson K2, Myrén KJ2. | ||||
Henry N1, Jovanović J1, Schlueter M1, Kritikou P2, Wilson K2, Myrén KJ2. 1 IQVIA , London , UK. 2 Swedish Orphan Biovitrum AB , Stockholm , Sweden. | ||||
, Article | ||||
, Nordic, UK | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Rare disease | 2018 | English | , Retrospective database analysis | |
Can patients accurately report their drugs? -A comparison of self-reported medication with a national register in Denmark in a subset of the protect pregnancy cohort. | ||||
Bourke A, Laursen M, Dreyer N, Hallgreen CE, Blackburn S | ||||
Pharmacoepidemiol Drug Saf 2018; 27 (2):87 |
||||
, Poster | ||||
, Nordic | ||||
Condition | Year | Language | Analysis type | |
, Pregnancy, Womens Health | 2018 | English | ||
#2811 Initial treatment in patients (pts) diagnosed with non-small cell lung cancer (NSCLC) in Denmark from 2005-2015: The SCAN-LEAF study | ||||
Jens Benn Sørensen, Simon Ekman, Pia Horvat, Deborah Layton, Joseph Kim, Mats Rosenlund, Ariadna Juarez‐Garcia, Melinda Daumont, Hazel C. Jacobs, Laure Lacoin, Odd Terje Brustugun, Maria Planck | ||||
Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Department of Oncology, Karolinska University Hospital-Solna, Stockholm, Sweden; Real-World Evidence Solutions, IQVIA, London, UK; Data Science, IQVIA, London, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Uxbridge, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Braine-L?Alleud, Belgium; Department of Oncology, Radiumhospitalet, Oslo, Norway; Division of Oncology and Pathology, Skane University Hospital-Lund, Lund, Sweden | ||||
, Poster | ||||
, England, Nordic, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Retrospective cohort analysis | |
Predictors and diseasburden of ulcerative colitis progression in Sweden. | ||||
Stålhammar J1,Hällström P1, Agreus L2, Beydogan H3, Arnheim Dahlström L3, Skup M4, Lee W-J4 | ||||
1 Uppsala University, Uppsala, Sweden 2 Karolinska Institutet, Stockholm, Sweden 3 QuintilesIMS, Stockholm, Sweden 4 AbbVie Inc., North Chicago, USA. | ||||
UEG Barcelona September 2017 |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2017 | English | , Retrospective cohort analysis | |
Description of a national pulmonary fibrosis cohort in Sweden. | ||||
Bartley K1, A Levine A2, Arnheim-Dahlstrom L2, Ferrara G3,4, Kirchgaessler K5, Linder R2, Janson C6, Sköld CM3 | ||||
1 Genentech, Inc., South San Francisco, CA, USA 2 IMS Health, Solna, Sweden 3 Karolinska University Hospital, Stockholm, Sweden 4 Karolinska Institutet, Stockholm, Sweden 5 Hoffmann-La Roche, Ltd., Basel, Switzerland 6Uppsala University, Uppsala, Sweden | ||||
British Thoracic Society Winter Meeting 2017, London |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2017 | English | , Retrospective cohort analysis | |
Market share and switching dynamics between Etanercept and its biosimilar product in Sweden and Germany: a real-world preliminary analysis. | ||||
Alten R1, Neregård P2, Jones HE3, Meng T4, Curiale C5, Singh E6, Lucchese L7, Gossen N8, Bergman GJ9, Miglio C7 | ||||
1 Shlosspark-Klinik Teaching Hospital of the Charité, Berlin, Germany 2 Pfizer, Sollentuna, Sweden 3 Pfizer inc., Collegeville, PA, USA 4 Pfizer Pharma GmbH, Berlin, Germany 5 Pfizer, Rome, Italy 6 Pfizer Inc., Collegeville, PA, USA 7 QuintilesIMS, London, UK 8 QuintilesIMS, Frankfurt, Germany 9 QuintilesIMS, Solna, Sweden | ||||
ISPOR 20th Annual European Congress |
||||
, Germany, Nordic, Sweden | ||||
Abstract: https://www.ispor.org/Event/ProgramList/2017Glasgow?type=Poster&sess=II&acode=PSY | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Patient Registries & Real-World Study Methods, Rheumatology | 2017 | English | , Retrospective database analysis | |
Prevalence, characteristics and management of asthma patients with frequent exacerbations ? an observational study in Sweden (PACEHR). | ||||
Janson C1, Lisspers K2, Ställberg B2, Johansson G3, Thuresson M4, Telg G4, Larsson K5. | ||||
1 Department of Medical Sciences, Respiratory Medicine, Uppsala University, Uppsala, Sweden 2 Department of Public Health and Caring Science, Family Medicine and Clinical Epidemiology, Uppsala University, Uppsala, Sweden 3 Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden. 4 Faculty of Medicine, University of Iceland, Reykjavik, Iceland. 5 Unit of Lung and Allergy Research, National Institute of Environmental Medicine, Karolinska Institute, Stockholm | ||||
, Abstract | ||||
, Nordic, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2017 | English | ||
Healthcare resource utilization associated with heart failure with preserved versus reduced ejection fraction: a retrospective population-based cohort study in Sweden | ||||
Boman K, Lindmark K, Olofsson M, Stalhammar J, Bergman GJ, Tornblom M, Bruce Wirta S, Costa-Scharplatz M, Calado F, Wikstrom G | ||||
Umea University, Research Unit, Medicine, Skellefteå, Department of Public Health and Clinical Medicine, Umea, Sweden|QuintilesIMS, Solna, Sweden | ||||
European Journal of Heart Failure (2017); 19 (Suppl. S1): 5–601 |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.833 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2017 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Population Based Study, Retrospective database analysis | |
Management of Patients with Heart Failure with Preserved Versus Reduced Ejection Fraction: A Retrospective Population-Based Cohort Study in Sweden | ||||
Stålhammar J, Boman K, Olofsson M, Wikström G, Jonasdottir Bergman G, Törnblom M, Wintzell V, Bruce Wirta S, Proenca CC, Schlienger R, Lindmark K | ||||
Uppsala University, Department of Public Health and Caring Sciences - Uppsala - Sweden | ||||
European Journal of Heart Failure ( 2017 );19(Suppl. S1):54 |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Abstract: https://esc365.escardio.org/Congress/Heart-Failure-2017-4th-World-Congress-on-Acute-Heart-Failure/Poster-Session-1-Chronic-heart-failure/152428-management-of-patients-with-heart-failure-with-preserved-versus-reduced-ejection-fraction-a-retrospective-population-based-cohort-study-in-sweden | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2017 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Population Based Study, Retrospective database analysis | |
Drug Treatment Patterns in Patients Newly Diagnosed with Heart Failure: A Retrospective Population-Based Cohort Study in Sweden | ||||
Wikström G, Lindmark K, Olofsson M, Stålhammar J, Jonasdottir Bergman G, Johansson S, Wintzell V., Bruce Wirta S, Balas B, Boman K | ||||
Uppsala University, Institute for Medical Sciences - Uppsala - Sweden||IMS Health Sweden, Stockholm, Sweden | ||||
European Journal of Heart Failure ( 2017 ) 19 ( Suppl. S1 ), 55 |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: https://esc365.escardio.org/Congress/Heart-Failure-2017-4th-World-Congress-on-Acute-Heart-Failure/Poster-Session-1-Chronic-heart-failure/152433-drug-treatment-patterns-in-patients-newly-diagnosed-with-heart-failure-a-retrospective-population-based-cohort-study-in-sweden | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2017 | English | , Population Based Study, Retrospective cohort analysis | |
Characteristics of asthma patients with frequent exacerbations ? an observational study in Sweden | ||||
Janson C, Lisspers K, Ställberg B, Johansson G, Thuresson M, Telg G, Larsson K | ||||
Uppsala University, Uppsala, Sweden | ||||
European Journal of Respiratory Research (2017) 50: PA3870 |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: http://erj.ersjournals.com/content/50/suppl_61/PA3870 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2017 | English | , Population Based Study, Retrospective cohort analysis | |
Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study | ||||
Tiihonen J, Tanskanen A, Hoti F, Vattulainen P, Taipale H, Mehtälä J, Lähteenvuo M | ||||
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden | ||||
European Neuropsychopharmacology(2017);27(4): S855–S856 |
||||
, Poster | ||||
, Finland, Nordic | ||||
Abstract: https://www.europeanneuropsychopharmacology.com/article/S0924-977X(17)31536-5/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Population Based Study, Retrospective database analysis | |
Long-term patterns of adherence to medication therapy among patients with type 2 diabetes mellitus in Denmark: The importance of initiation | ||||
Jensen ML1,2, Jørgensen ME1, Hansen EH2, Aagaard L3, Carstensen B1. | ||||
1 Steno Diabetes Center Copenhagen, Gentofte, Denmark. QuintilesIMS 2 Faculty of Health and Medical Sciences, Department of Pharmacy, Section for Social and Clinical Pharmacy, Universitetsparken 2, University of Copenhagen,Denmark. 3 Faculty of Health, University of Southern Denmark, Odense, Denmark. | ||||
PLoS One. 2017; 12(6): e0179546. |
||||
, Article | ||||
, Denmark, Nordic | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493299/ | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Diabetes | 2017 | English | , clinical setting: Secondary care, Compliance, Epidemiological study, Retrospective cohort analysis | |
Antibiotic prescribing during infancy and risk of treated airway diseases among children born in Denmark 2004-2012. | ||||
Kinlaw A, Sørensen HT, Lund JL, Mack CD, Lars P, Daniels JL, Kappelman MD, Stürmer T. | ||||
Triangle Comparative Effectiveness Research Symposium | ||||
, Presentation | ||||
, Nordic | ||||
Condition | Year | Language | Analysis type | |
, Pregnancy | 2017 | English | ||
Clinical Effectiveness of Liraglutide vs Sitagliptin on Glycemic Control and Body Weight in Patients with Type 2 Diabetes: A Retrospective Assessment in Sweden | ||||
Lind M1,2, Matsson PO3, Linder R4, Svenningsson I5, Jørgensen L6, Ploug UJ7, Gydesen H7, Dorkhan M8, Larsen S8, Johansson G9. | ||||
1Department of Medicine, NU-Hospital Group, Trollhättan/Uddevalla, Sweden. lind.marcus@telia.com. 2Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden. lind.marcus@telia.com. 3Domnarvet VC, Borlänge, Sweden. 4Pygargus, Stockholm, Sweden. 5Research and Development Unit, Primary Health Care, Närhälsan, Vänersborg, Sweden. 6IMS Health, Stockholm, Sweden. 7Novo Nordisk A/S, Søborg, Denmark. 8Novo Nordisk Scandinavia AB, Malmö, Sweden. 9Department of Caring Sciences and Family Medicine, Uppsala University, Uppsala, Sweden. | ||||
Diabetes Ther |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900983/ | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2016 | English | , Retrospective cohort analysis | |
Population-based study of giant cell tumor of bone in Sweden (1983-2011). | ||||
Amelio JM1, Rockberg J2, Hernandez RK3, Sobocki P4, Stryker S5, Bach BA3, Engellau J6, Liede A5 | ||||
1Amgen Ltd. Uxbridge, UK. Electronic address: justyna.amelio@amgen.com. 2Pygargus/IMS Health, Stockholm, Sweden. 3Amgen Inc. Thousand Oaks, CA, USA. 4Pygargus/IMS Health, Stockholm, Sweden; Karolinska Institutet, Stockholm, Sweden. 5Amgen Inc. South San Francisco, CA, USA. 6Lund University, Lund, Sweden. | ||||
Cancer Epidemiol |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: http://www.cancerepidemiology.net/article/S1877-7821(16)30039-X/abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Real World Evidence | |
Lipid-lowering treatment patterns in patients with new cardiovascular events - estimates from population-based register data in Sweden. | ||||
Hallberg S1, Banefelt J1, Fox KM2, Mesterton J1,3, Johansson G4, Levin LÅ5, Sobocki P3,6, Gandra SR7. | ||||
1Quantify Research, Stockholm, Sweden. 2Strategic Healthcare Solutions, LLC, Baltimore, MD, USA. 3LIME/Medical Management Centre, Karolinska Institute, Stockholm, Sweden. 4Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden. 5Department of Medical and Health Sciences, Linköping University, Linköping, Sweden. 6IMS Health, Stockholm, Sweden. 7Amgen Inc., Thousand Oaks, CA, United States. | ||||
Int J Clin Pract |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819716/ | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | , Epidemiological study | |
Exposure to heart failure treatments in newly diagnosed patients in Sweden | ||||
G Wikstrom1, K Boman2, M Olofsson2, K Lindmark3, R Lahoz4, S Corda4, V Wintzell5, R Linder5, A Gondos6, J Stalhammar7, | ||||
1Uppsala University, Institute for Medical Sciences - Uppsala - Sweden, 2Umea University, Department of Public Health and Clinical Medicine - Umea - Sweden, 3Umea University, Heart Centre, Department of Public Health and Clinical Medicine - Umea - Sweden, 4Novartis Pharma AG - Basel - Switzerland, 5IMS Health Sweden - Stockholm - Sweden, 6IMS Health Germany - Berlin - Germany, 7Uppsala University, Department of Public Health and Caring Sciences - Uppsala - Sweden | ||||
European Journal of Heart Failure, 2016, Vol. 18, 48-48 p. |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: http://onlinelibrary.wiley.com/doi/10.1002/ejhf.539/epdf | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | , Real World Evidence | |
Dosing of heart failure treatments in newly diagnosed unselected patients in Sweden: compliance with European society of cardiology guidelines | ||||
G Wikstrom1, K Boman2, M Olofsson2, K Lindmark3, R Lahoz4, S Corda4, V Wintzell5, R Linder5, A Gondos6, J Stalhammar7 | ||||
1Uppsala University, Institute for Medical Sciences - Uppsala - Sweden, 2Umea University, Research Unit, Medicine and Geriatric, Skellefteå County Hospital, Department of Public Health - Umea - Sweden, 3Umea University, Heart Centre, Department of Public Health and Clinical Medicine - Umea - Sweden, 4Novartis Pharma AG - Basel - Switzerland, 5IMS Health Sweden - Stockholm - Sweden, 6IMS Health Germany - Berlin - Germany, 7Uppsala University, Department of Public Health and Caring Sciences - Uppsala - Sweden | ||||
European Journal of Heart Failure |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: http://onlinelibrary.wiley.com/doi/10.1002/ejhf.539/epdf | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | , Real World Evidence | |
Epidemiology of cutaneous melanoma in Sweden-Stage-specific survival and rate of recurrence. | ||||
Rockberg J1, Amelio JM2, Taylor A2, Jörgensen L1, Ragnhammar P3, Hansson J4. | ||||
1Pygargus AB/IMS Health Sweden AB, Pyramidvägen 7, Solna, Sweden 169 56. 2Amgen Inc, Uxbridge Business Park, Uxbridge, UK UB8 1DH. 3Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden 171 76. 4Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden 171 76. johan.hansson@ki.se. | ||||
Int J Cancer |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/27563839 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Epidemiological study, Real World Evidence | |
COPD Patients Initiating Roflumilast in Sweden, Germany and the United States: Findings from the Roflumilast PASS Study | ||||
Hoti F, Mushnikov V, Mehtälä J, et al. | ||||
32nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management; 2016; Dublin, Ireland |
||||
, Abstract | ||||
, Germany, Nordic, Sweden, USA | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2016 | English | , Real World Evidence | |
Dosing of heart failure treatments in newly diagnosed unselected patients in sweden: compliance with european society of cardiology guidelines | ||||
Wikström G, Boman K, Olofsson M, Lindmark K, Lahoz R, Corda S, Wintzell V, Linder R, Gondos A, Stalhammer J | ||||
Uppsala University, Institute for Medical Sciences, Uppsala, Sweden|IMS Health Sweden, Stockholm, Sweden | ||||
European Journal of Heart Failure. (2016) 18:341-341 |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.539 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Population Based Study | |
Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden | ||||
Banefelt J, Hallberg S, Fox K M, Mesterton J, Paoli C J, Johansson G, Levin L-Å, Sobocki P, Gandra S R | ||||
Quantify Research Stockholm Sweden|IMS Health Stockholm Sweden | ||||
Eur J Health Econ (2016) 17: 1117 |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: https://link.springer.com/article/10.1007/s10198-015-0749-y | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | , Cost of illness, Population Based Study, Retrospective cohort analysis | |
The Quality of Warfarin Therapy Among Atrial Fibrillation Patients in Finland ? Results from the FinWAF Registry | ||||
Mehtälä J, Raatikainen P, Lassila R, Khanfir H, Korhonen P, Hoti F, Lehto M | ||||
EPID Research, Espoo, Finland | ||||
Pharmacoepidemiology and Drug Safety (2016);25(Suppl. 3): pp. 3-680 |
||||
, Abstract | ||||
, Finland, Nordic | ||||
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/pds.4070 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | , Population Based Study, Retrospective database analysis | |
Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: a nationwide cohort study from Finland | ||||
Prami T, Khanfir H, Deleskog A, Hasvold P, Kytö V, Reissell E, Airaksinen J | ||||
EPID Research, Espoo, Finland | ||||
BMJ Open (2016) 6:e012604 |
||||
, Article | ||||
, Finland, Nordic | ||||
Abstract: https://bmjopen.bmj.com/content/6/11/e012604.short | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | , Population Based Study, Retrospective database analysis | |
Age predicts initiation of and persistence with P2Y12 inhibitor treatment after acute coronary syndrome - results form a nationwide retrospective cohort in Finland | ||||
Prami T, Khanfir H, Deleskog A, Hasvold P, Kytö V, Reissell E, Airaksinen J | ||||
EPID Research, Espoo, Finland | ||||
European Heart Journal (2016 );37 ( Abstract Supplement ):939 |
||||
, Poster | ||||
, Finland, Nordic | ||||
Abstract: https://esc365.escardio.org/Congress/ESC-CONGRESS-2016/Poster-session-5-Are-we-better-at-managing-cardiovascular-disease-in-the-el/139119-age-predicts-initiation-of-and-persistence-with-p2y12-inhibitor-treatment-after-acute-coronary-syndrome-results-from-a-nationwide-retrospective-cohort-in-finland | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | , Population Based Study, Retrospective database analysis | |
Gender differences in oral antiplatelet treatment use - results from a nationwide cohort study of acute coronary syndrome patients in Finland. | ||||
Prami T, Khanfir H, Deleskog A, Hasvold P, Kytö V, Reissell E, Airaksinen J. | ||||
EPID Research, Espoo, Finland | ||||
European Heart Journal (2016);37(Abstract Supplement);378-379 |
||||
, Poster | ||||
, Finland, Nordic | ||||
Abstract: https://esc365.escardio.org/Congress/ESC-CONGRESS-2016/Poster-session-2-Clinical-platelet-studies/140660-gender-differences-in-oral-antiplatelet-treatment-use-results-from-a-nationwide-cohort-study-of-acute-coronary-syndrome-patients-in-finland | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | , Epidemiological study, Population Based Study, Retrospective database analysis | |
Cost-effectiveness analysis of a low-dose contraceptive levonorgestrel intrauterine system in Sweden | ||||
Henry N1, Hawes C1, Lowin J1, Lekander I2, Filonenko A3, Kallner HK4. | ||||
1IMS Health, London, UK. 2Bayer AB, Solna, Sweden. 3Bayer Pharma AG, Berlin, Germany. 4Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden. | ||||
Acta Obstet Gynecol Scand. 2015 Aug;94(8):884-90 |
||||
, Article | ||||
, Nordic, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Womens Health | 2015 | English | , Cost effectiveness | |
COST-EFFECTIVENESS OF DULAGLUTIDE 1.5MG ONCE WEEKLY FOR THE TREATMENT OF PATIENTS WITH TYPE TWO DIABETES MELLITUS IN SWEDEN | ||||
Raibouaa A1, Borgeke H2, Alexiou D3, Lowin J3, Norrbacka K4 | ||||
1Eli Lilly and Company Limited, Windlesham, Surrey, UK, 2Eli Lilly Sweden AB, Solna, Sweden, 3IMS Health, London, UK, 4Eli Lilly and Company, Helsinki, Finland | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Condition | Year | Language | Analysis type | |
2015 | English | |||
Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden. | ||||
Banefelt J1, Hallberg S2, Fox KM3, Mesterton J2,4, Paoli CJ5, Johansson G6, Levin LÅ7, Sobocki P4,8, Gandra SR5. | ||||
1Quantify Research, Hantverkargatan 8, 112 21, Stockholm, Sweden. jonas.banefelt@quantifyresearch.com. 2Quantify Research, Hantverkargatan 8, 112 21, Stockholm, Sweden. 3Strategic Healthcare Solutions, LLC, Baltimore, MD, USA. 4LIME/Medical Management Centre, Karolinska Institute, Stockholm, Sweden. 5Amgen Inc., Thousand Oaks, CA, USA. 6Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden. 7Department of Medical and Health Sciences, Linköping University, Linköping, Sweden. 8IMS Health, Stockholm, Sweden. | ||||
Eur J Health Econ |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: http://link.springer.com/article/10.1007%2Fs10198-015-0749-y | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2015 | English | , Real World Evidence | |
Incidence Trends in the Diagnosis of Giant Cell Tumor of Bone in Sweden Since 1958. | ||||
Rockberg J1, Bach BA2, Amelio J3, Hernandez RK4, Sobocki P1, Engellau J5, Bauer HC6, Liede A7. | ||||
1IMS Health (Pygargus), Sveavägen 155, SE-113 46, Stockholm, Sweden. 2Amgen Inc., One Amgen Center Drive, MS 38-2-B, Thousand Oaks, CA 91320-1799. 3Amgen Ltd, 1 Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, England. 4Amgen Inc., One Amgen Center Drive, MS 24-2-A, Thousand Oaks, CA 93120-1799. 5Lund University, SE-221 85 Lund, Sweden. 6Karolinska Universitetssjukhuset, Solna, A2:07,171 76 Stockholm, Sweden. 7Center for Observational Research, Amgen, Inc., 1120 Veterans Boulevard, ASF3, South San Francisco, CA 94080. E-mail address: aliede@amgen.com. | ||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: http://jbjs.org/content/97/21/1756.long | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Real World Evidence | |
Estimating Rates of Cardiovascular Death Using Royston-Parmar Survival Models: An Example in a High Risk Patient Population in Sweden | ||||
Julia Sandberg1, Leif Jorgensen1, Mark Danese2, Benjamin Taylor3, Ryan Kilpatrick4 and Patrik Sobocki1 | ||||
1 IMS Health Sweden, 2 Outcomes Insights Inc. CA USA, 3 Amgen Inc. CA USA, 4 GSK NC USA | ||||
Circulation |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: http://circ.ahajournals.org/content/131/Suppl_1/AP233.abstract | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2015 | English | , Real World Evidence | |
Characteristics, Referral and Treatment Patterns of Patients Diagnosed with Psoriatic Arthritis ? A Retrospective Cohort Study Based in Sweden | ||||
J. Rockberg1, M. Mittal2, A. Joshi2, Y. Bao2, J. Anderson3, R. Linder1, J. Stålhammar4, U. Lindqvist5 | ||||
1Real World Evidence Solutions & HEOR, Pygargus AB/IMS Health, Stockholm, Sweden 2Health Economics and Outcomes Research (HEOR) 3Immunology Clinical Development, AbbVie Inc, Chicago, United States 4Department of Public health and Caring Sciences; Family Medicine and Preventive Medicine 5Department of Medical Sciences, Uppsala University, Uppsala, Sweden | ||||
Ann Rheum Dis |
||||
, Oral presentation | ||||
, Nordic, Sweden | ||||
Abstract: http://ard.bmj.com/content/74/Suppl_2/64.2 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2015 | English | , Real World Evidence | |
Healthcare utilization and costs following newly diagnosed type-2 diabetes in Sweden: A follow-up of 38,956 patients in a clinical practice setting | ||||
Sabale U1, Bodegård J2, Sundström J3, Östgren CJ4, Nilsson P5, Johansson G3, Svennblad B3, Henriksson M2. | ||||
1AstraZeneca Nordic-Baltic, Södertälje, Sweden. Electronic address: ugne.sabale@astrazeneca.com. 2AstraZeneca Nordic-Baltic, Södertälje, Sweden. 3Uppsala University, Uppsala, Sweden. 4Linköping University, Linköping, Sweden. 5Lund University, Malmö, Sweden | ||||
Prim Care Diabetes |
||||
, Nordic, Sweden | ||||
Abstract: http://www.primary-care-diabetes.com/article/S1751-9918(15)00002-9/abstract | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2015 | English | , Cost of illness, Real World Evidence | |
Weight change over time and its link to healthcare costs among newly-diagnosed type 2 diabetes patients in Sweden | ||||
U. Sabale1, J. Bodegard1, J. Sundström2, B. Svennblad2, C. Östgren3, P.M. Nilsson4, G. Johansson2, M.Ekman1 | ||||
1AstraZeneca, Södertälje, 2Uppsala University, Uppsala, 3Linköping University, Linköping, 4Lund University, Malmö, Sweden. | ||||
European Association for the Study of Diabetes (EASD) Annual Meeting; 2015; Stockholm. |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: http://staging.easdvirtualmeeting.org/resources/weight-change-over-time-and-its-link-to-healthcare-costs-among-newly-diagnosed-type-2-diabetes-patients-in-sweden--2 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2015 | English | , Real World Evidence | |
Psychotropic drugs and homicide: a prospective cohort study from Finland | ||||
Tiihonen J, Lehti M, Aaltonen M, Kivivuori J, Kautiainen H, Virta L, Hoti F, Tanskanen A, Korhonen P | ||||
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden | ||||
World Psychiatry. (2015) 14(2):245-7 |
||||
, Letter | ||||
, Finland, Nordic | ||||
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1002/wps.20220 | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2015 | English | , Population Based Study, Prospective study | |
Cost-effectiveness of dulaglutide 1.5mg once weekly for the treatment of patients with type two diabetes mellitus in Sweden | ||||
Raibouaa A1, Borgeke H2, Alexiou D3, Lowin J3, Norrbacka K4 | ||||
1Eli Lilly and Company Limited, Windlesham, Surrey, UK, 2Eli Lilly Sweden AB, Solna, Sweden, 3IMS Health, London, UK, 4Eli Lilly and Company, Helsinki, Finland | ||||
ISPOR, 18th Annual European Congress,7-11 November 2015 |
||||
, Abstract | ||||
, Italy, Nordic | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2015 | English | , Cost effectiveness | |
Cost of unintended pregnancy in Norway: a role for long-acting reversible contraception | ||||
Henry N1, Schlueter M1, Lowin J1, Lekander I2, Filonenko A3, Trussell J4, Skjeldestad FE5 | ||||
1 Real World Evidence Solutions, IMS Health, London, UK. 2 Bayer AB, Solna, Sweden. 3 Bayer Pharma AG, Berlin, Germany. 4 Office of Population Research, Princeton University, Princeton, NJ, USA. 5 Department of Clinical Medicine, University of Tromsø, Tromsø, Norway | ||||
, Article | ||||
, Nordic, UK | ||||
Condition | Year | Language | Analysis type | |
, Pregnancy | 2015 | English | , Retrospective database analysis | |
Population-based study of giant cell tumour of the bone in Sweden | ||||
Amelio J1, Sandberg J2, Hernandez RK4, Sobocki P2,Stryker S4, Engellau J3, Bach BA4, Liede A4 | ||||
1Center For Oberservational Research, Amgen Ltd., UB8 1DH - Uxbridge/UK 2., IMS Health, 113 46 - Stockholm/SE 3Center For Oberservational Research, Amgen Inc., Thousand Oaks/US 4Department Of oncology, Lund University Hospital, 221 00 - Lund/SE | ||||
ESMO 2014 CTOS 19th Annual Meeting, October 15- 18, 2014 at the InterContinental Hotel in Berlin, Germany |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Sarcoma/Population-based-study-of-giant-cell-tumour-of-the-bone-in-Sweden | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Database Study | |
Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia - estimates from population-based register data in Sweden | ||||
Banefelt J1, Hallberg S1, Fox KM2, Mesterton J1, Paoli CJ3, Johansson G4, Levin L5, Sobocki P6, Gandra SR3 | ||||
1Quantify Research, Stockholm, Sweden, 2Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 3Amgen, Inc., Thousand Oaks, CA, USA, 4Uppsala University, Uppsala, Sweden, 5Linköping University, Linköping, Sweden, 6IMS Health, Stockholm, Sweden | ||||
ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 8-12 November, 2014 |
||||
, Podium presentation | ||||
, Nordic, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2014 | English | , Cost of illness | |
Burden of hyperlipidemia resulting from productivity loss - estimates from population-based register data in Sweden | ||||
Banefelt J1, Hallberg S1, Gandra SR2, Mesterton J1, Fox KM3, Paoli CJ2, Johansson G4, Levin L5, Sobocki P6 | ||||
Quantify Research, Stockholm, Sweden, 2Amgen, Inc., Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 4Uppsala University, Uppsala, Sweden, 5Linköping University, Linköping, Sweden, 6IMS Health, Stockholm, Sweden | ||||
ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 8-12 November, 2014 |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2014 | English | , Burden of illness | |
Transforming oncology outcomes research through data linkage in Sweden: A unique real-world lens on the entire patient journey | ||||
Sobocki P | ||||
IMS Health, Stockholm, Sweden | ||||
AccessPoint, 2014, May; 4(8): 21-25 |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Oncology | 2014 | English | , Real World Evidence | |
HEALTH CARE COSTS ASSOCIATED WITH CARDIOVASCULAR EVENTS IN PATIENTS WITH HYPERLIPIDEMIA - ESTIMATES FROM POPULATION-BASED REGISTER DATA IN SWEDEN | ||||
Hallberg S1, Banefelt J1, Mesterton J1, Gandra SR2, Fox KM3, Johansson G4, Levin L5, Sobocki P6 | ||||
1Quantify Research, Stockholm, Sweden, 2Amgen, Inc., Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 4Uppsala University, Uppsala, Sweden, 5Linköping University, Linköping, Sweden, 6IMS Health, Stockholm, Sweden | ||||
ISPOR 17th Annual European Congress Amsterdam, The Netherlands November, 2014 |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: http://www.ispor.org/research_study_digest/details.asp | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2014 | English | , Real World Evidence | |
LDL-C goal attainment in patients with hyperlipidemia - estimates from population-based register data in Sweden | ||||
Mesterton J1, Hallberg S1, Gandra SR2, Banefelt J1, Fox KM3, Johansson G4, Levin L5, Sobocki P6 | ||||
Quantify Research, Stockholm, Sweden, 2Amgen, Inc., Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 4Uppsala University, Uppsala, Sweden, 5Linköping University, Linköping, Sweden, 6IMS Health, Stockholm, Sweden | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2014 | English | , Population Based Study | |
Treatment patterns in hyperlipidemia patients with new cardiovascular events - estimates from population-based register data in Sweden | ||||
Hallberg S1, Banefelt J1, Fox KM2, Mesterton J1, Johansson G3, Levin L4, Sobocki P5, Gandra SR6 | ||||
1Quantify Research, Stockholm, Sweden, 2Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 3Uppsala University, Uppsala, Sweden, 4Linköping University, Linköping, Sweden, 5IMS Health, Stockholm, Sweden, 6Amgen, Inc., Thousand Oaks, CA, USA | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2014 | English | , Database Study | |
Retrospective database study on healthcare resource utilization of patients initiating long-acting olanzapine in Sweden | ||||
Tockhorn A1, Johansson S2, Borgeke H3 | ||||
1Eli Lilly UK, Windlesham, Surrey, UK, 2IMS Health Sweden, 113 46 Stockholm, Sweden, 3Eli Lilly and Company, Stockholm, Sweden | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2014 | English | , Retrospective database analysis | |
Cost-effectiveness of ipilimumab in previously untreated patients for advanced melanoma in Sweden | ||||
Barzey V1, Asukai Y1, Gueron B2, Holmberg C3, Kotapati S4 | ||||
1IMS Health, London, UK, 2Bristol-Myers Squibb, Rueil Malmasion, France, 3Bristol-Myers Squibb, Bromma, Sweden, 4Bristol-Myers Squibb Pharmaceuticals, Wallingford, CT, USA | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Cost effectiveness | |
Survival and clinical metastases among prostate cancer patients treated with androgen deprivation therapy in Sweden | ||||
Banefelt J1, Liede A2, Mesterton J3, Stålhammar J4, Hernandez RK5, Sobocki P6, Persson BE7. | ||||
1Quantify Research, Hantverkargatan 8, 112 21 Stockholm, Sweden. 2Amgen Inc., Center for Observational Research, South San Francisco, CA, United States. 3Quantify Research, Hantverkargatan 8, 112 21 Stockholm, Sweden; Institute of Environmental Medicine, Karolinska Institute, 171 77 Stockholm, Sweden. 4Department of Public Health and Caring Sciences, Uppsala University, 751 22 Uppsala, Sweden. 5Amgen Inc., Center for Observational Research, One Amgen Center Drive 24-2-A, Thousand Oaks, CA 91320, United States. 6IMS Health/Pygargus, Sveavägen 155, 113 46 Stockholm, Sweden; LIME/Medical Management Centre, Karolinska Institute, 171 77 Stockholm, Sweden. 7Uppsala University, 751 05 Uppsala, Sweden. Electronic address: Bo-Eric.Persson@ferring.com. | ||||
Cancer Epidemiol |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: http://www.cancerepidemiology.net/article/S1877-7821(14)00089-7/abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Real World Evidence | |
Burden Of Hyperlipidemia Resulting From Productivity Loss - Estimates From Population-Based Register Data In Sweden | ||||
Banefelt J.1, Hallberg S.1, Gandra S.R.2, Mesterton J.1, Fox K.M.3, Paoli C.J.2, Johansson G.4, Levin L.Å.5, Sobocki P.6 | ||||
1Quantify Research, Stockholm, Sweden, 2Amgen, Inc., Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 4Uppsala University, Uppsala, Sweden, 5Linköping University, Linköping, Sweden, 6IMS Health, Stockholm, Sweden | ||||
Value in Health |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(14)03384-1/abstract | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2014 | English | , Real World Evidence | |
Trends in giant cell tumour of the bone and osteosarcoma incidence in the Sweden (1958-2011. | ||||
A. Liede1, J. Sandberg2, J. Amelio3, R.K. Hernandez4, P. Sobocki2, H.C..F. Bauer5, B. Bach6, J. Engellau7 | ||||
1Center For Observational Research, Amgen Inc., 94080 - South San Francisco/US 2., IMS Health, 113 46 - Stockholm/SE 3Center For Oberservational Research, Amgen Ltd., UB8 1DH - Uxbridge/UK 4Center For Observational Research, Amgen Inc., 91320 - Thousand Oaks/US 5Molecular Medicine And Surgery, Karolinska Institute, Stockholm/SE 6Clinical Development, Amgen Inc., Thousand Oaks/US 7Department Of Oncology, Lund University Hospital, 221 00 - Lund/SE | ||||
European Society for Medical Oncology (ESMO) Meeting 2014, Madrid Spain, 29 September |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Sarcoma/Trends-in-Giant-Cell-Tumour-of-the-Bone-and-Osteosarcoma-Incidence-in-the-Sweden-1958-2011 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Real World Evidence | |
Management, morbidity and mortality of COPD during an 11-year period: an observational retrospective epidemiological register study in Sweden (PATHOS) | ||||
Ställberg B1, Janson C, Johansson G, Larsson K, Stratelis G, Telg G, Lisspers KH. | ||||
1Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden | ||||
Prim Care Respir J |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: http://www.nature.com/articles/pcrj2013106 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2014 | English | , Epidemiological study, Real World Evidence | |
Patients with COPD who Initiate Roflumilast in Sweden | ||||
Khalid J.M.1, Mushnikov V.2, Vattulainen P.2, Johansson G.3, Korhonen P. 2, Hoti F.2 | ||||
1Takeda Development Centre Europe, Ltd., London, UK, 2EPID Research, Espoo, Finland, 3Uppsala University, Uppsala, Sweden | ||||
ISPOR 17th Annual European Congress, nov 8-12, 2014, Amsterdam, The Netherlands. |
||||
, Nordic, Sweden | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(14)03952-7/abstract | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2014 | English | , Real World Evidence | |
Association of Changes In Body Weight With Health Care Costs Among Patients With Newly-Diagnosed Type-2 Diabetes In Sweden | ||||
U. Sabale1, J. Bodegård1, J. Sundström2, B. Svennblad3, C.J. Östgren4, P. Nilsson5, G. Johansson3, M. Henriksson1 | ||||
1 AstraZeneca Nordic-Baltic, Södertälje, Sweden, 2 Uppsala University, Uppsala, Australia, 3 Uppsala University, Uppsala, Sweden, 4 Linköping University, Linköping, Sweden, 5 Lund University, Malmö, Sweden | ||||
Value in Health |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: http://www.sciencedirect.com/science/article/pii/S109830151402590X | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2014 | English | , Real World Evidence | |
Population-based study of Giant Cell Tumor of the bone in Sweden | ||||
Amelio J, Sandberg J, Hernandez R, Sobocki P, Stryker S, Engellau J, Bach B, Liede A | ||||
Center for Oberservational Research, Amgen Ltd., Uxbridge, UK|IMS Health, Stockholm Sweden | ||||
Annals of Oncology (2014) 25(suppl 4):iv509-iv510 |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Abstract: https://academic.oup.com/annonc/article/25/suppl_4/iv509/2242151 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Epidemiological study, Population Based Study, Retrospective database analysis | |
Work Productivity Loss and Indirect Costs Associated with New Cardiovascular Events in High-Risk Patients with Hyperlipidemia - Estimates from Population-Based Register Data in Sweden | ||||
Banefelt J, Hallberg S, Fox KM, Mesterton J, Paoli CJ, Johansson G, Levin LA, Sobocki P, Gandra SR | ||||
Quantify Research, Stockholm, Sweden|IMS Health, Stockholm, Sweden | ||||
Value in health:The journal of the International Society for Pharmacoeconomics and Outcomes Research (2014);17(7):A327-328 |
||||
, Oral presentation | ||||
, Nordic, Sweden | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(14)02526-1/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2014 | English | , Cost analysis, Cost of illness, Population Based Study, Retrospective database analysis | |
Exacerbations and healthcare resource utilization among COPD patients in Sweden | ||||
Hoti F, Mushnikov V, Vattulainen P, Johansson G, Khalid JM, Korhonen P | ||||
EPID Research, Espoo, Finland | ||||
ERS International Congress 2014, Munich, Germany, 6-10 Sep, 2014 |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Abstract: http://epidresearch.com/wp-content/uploads/2016/11/EPID-Research-poster-ERS-2014.pdf | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2014 | English | , Burden of illness, Clinical setting: hospital, clinical setting: Secondary care, Population Based Study, Retrospective database analysis | |
Patients With COPD who Initiate Roflumilast in Sweden | ||||
Khalid JM, Mushnikov V, Vattulainen P, Johansson G, Korhonen P, Hoti F | ||||
Takeda Development Centre Europe, Ltd., London, UK. | ||||
Value Health (2014);17(7): A590 |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Abstract: https://ac.els-cdn.com/S1098301514039527/1-s2.0-S1098301514039527-main.pdf?_tid=8ac08c65-061d-4f1f-9dd7-ab7e57390da9&acdnat=1537855638_d812a58ce69b69727a8d22b21f1ed84a | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2014 | English | , Observational study, Population Based Study | |
ASSOCIATION OF CHANGES IN BODY WEIGHT WITH HEALTH CARE COSTS AMONG PATIENTS WITH NEWLY-DIAGNOSED TYPE-2 DIABETES IN SWEDEN | ||||
Sabale U, Bodegård J, Sundström J, Svennblad B, Östgren CJ, Nilsson P, Johansson G, Henriksson M | ||||
AstraZeneca Nordic-Baltic, Södertälje, Sweden | ||||
Value in Health (2014);17(7): A338 |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(14)02590-X/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2014 | English | , Cost analysis, Population Based Study, Retrospective database analysis | |
Regional assessment of severe hypoglycemic coma events in Finland | ||||
Vattulainen P, Mushnikov V, Hoti F, Saukkonen T, Korhonen P. | ||||
EPID Research, Espoo, Finland | ||||
Value Health. (2014) 17(7): A332 |
||||
, Poster | ||||
, Finland, Nordic | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(14)02557-1/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2014 | English | , Epidemiological study, Observational study, Population Based Study | |
Lower Risk of Mortality in Patients with Type 2 Diabetes Using Insulins Detemir or Glargine Compared to NPH: A Propensity Score Matched Nationwide Register Study in Finland | ||||
Mäkimattila S, Hoti F, Christopher S, Haukka J, Korhonen P, Saukkonen T | ||||
EPID Research Ltd, Espoo, Finland | ||||
Diabetes (2014);63 (Suppl 1):A343-A425 |
||||
, Poster | ||||
, Finland, Nordic | ||||
Abstract: http://diabetes.diabetesjournals.org/mwg-internal/de5fs23hu73ds/progress?id=tLDZcQ3XmqwM1R5WmUnmnK6ZYf5Vk0j-7PYr0VdNiOQ,&dl | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2014 | English | , Retrospective database analysis | |
Uses of Electronic Patient Information Systems and National Registers ? Implementation of the Clinical Practice Guideline and Evaluation of Costs and Use of Resources in Patients with Incident Type 2 Diabetes in Finland | ||||
Prami T, Sulamaa A, Sipilä R, Linna M, Hahl J, Miettinen T, Leppä E, Haukka J, Tuomilehto J, Enlund H, Niskanen L, Korhonen P | ||||
EPID Research, Espoo, Finland | ||||
Value in Health. (2014);17(7): A336 |
||||
, Abstract | ||||
, Finland, Nordic | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(14)02579-0/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2014 | English | , Population Based Study | |
Regional Assessment of Severe Hypoglycemic Coma Events in Finland | ||||
Hoti F, Vattulainen P, Mushnikov V, Saukkonen T, Korhonen P | ||||
EPID Research, Espoo, Finland | ||||
Value in Health (2014);17(7):A332 |
||||
, Poster | ||||
, Finland, Nordic | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(14)02557-1/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2014 | English | , Epidemiological study, Observational study, Population Based Study | |
Health economic evaluation of canagliflozin in the treatment of type 2 diabetes mellitus in Norway | ||||
Troelsgaard A1, Huetson P2, Kjellberg J3, Hemels M1, Knudsen M4 | ||||
Janssen A/S, Birkerød, Denmark, 2IMS Health, Stockholm, Sweden, 3Zefferin Farma AB, Stockholm, Sweden, 4IMS Health, Hellerup, Denmark | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, Nordic, Norway | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2014 | English | , Economic evaluation | |
A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden | ||||
Fredrikson S1, McLeod E2, Henry N2, Pitcher A2, Lowin J2, Cuche M3, Fajutrao L4, Perard R5, Bates D6, Chan A7 | ||||
1 Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden 2 IMS Health, London, UK 3 Merck Serono S.A., Geneva, Switzerland 4 Merck AB, Solna, Sweden 5 Merck Serono Ltd, Middlesex, UK 6 Newcastle University, Newcastle upon Tyne, UK 7 Ruhr-University Bochum, St. Josef-Hospital, Bochum, Germany | ||||
J Med Econ. 2013;16(6):756-62. |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: http://informahealthcare.com/doi/abs/10.3111/13696998.2013.792824?journalCode=jme | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2013 | English | , Cost effectiveness | |
Length of stay and costs for patients with recurrent Clostridium Difficile infections in Sweden | ||||
Norén T1, Bruce S2, Fagerlund K3, Nordling S3 | ||||
1Department of Infectious Diseases, Örebro, Sweden, 2IMS Health, Stockholm, Sweden, 3Astellas Pharma Nordic, Kastrup, Denmark | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters2.aspx | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2012 | English | , Cost analysis | |
COPD in primary care in Sweden - An 11 years epidemiological register study | ||||
Karin Lisspers1, Kjell Larsson2, Björn Ställberg1, Christer Janson3, Gunilla Telg4, Leif Jörgensen4, Georgios Stratelis4 and Gunnar Johansson1 | ||||
1Department of Public Health and Caring Sciences, Family Medicine and Clinical Epidemiology, Uppsala University, Uppsala, Sweden 2Unit of Lung and Allergy Research, National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden 3Department of Medical Sciences, Respiratory Medicine, Uppsala University, Uppsala, Sweden 4Medical, AstraZeneca Nordic, Södertälje, Sweden | ||||
Eur Respir J |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: http://erj.ersjournals.com/content/40/Suppl_56/4339.article-info | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2012 | English | , Real World Evidence | |
Drug utilisation adaptions in Sweden after the Effexor patent expiry | ||||
Bruce S, Hjelmgren J, Löfroth E, Myrén KJ. | ||||
IMS Consulting Group, Stockholm, Sweden. | ||||
ISPOR 14th Annual European Congress, 2010, 5-8 November, Madrid, Spain |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Abstract: http://www.ispor.org/congresses/Spain1111/Posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Health policy, Mental health | 2011 | English | , Retrospective database analysis | |
Healthcare encounters among heart failure patients with preserved ejection fraction (HF-PEF) and reduced ejection fraction (HF-REF) in Sweden | ||||
Wikstrom G1, Stalhammar J2, Ariely R3, Linder R4, Ogbonnaya A5, Stern L5 | ||||
1Uppsala University, Department of Medical Sciences, Cardiology, Uppsala, Sweden, 2Uppsala University, Department of Public Health and Caring Sciences, Uppsala,Sweden, 3 Novartis Pharmaceuticals Corporation, East Hanover, USA, 4IMS Health (Formally Pygargus AB), Stockholm, Sweden, 5Analytica International, New York, USA | ||||
European Heart Failure Congress, Gothenbourg, May 21-24, 2011 |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: http://spo.escardio.org/SessionDetails.aspx?eevtid=46&sessId=7804&subSessId=1013&searchQuery=&presId=54107&doc=Abstract | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2011 | English | , Cost utility, Retrospective database analysis | |
Mortality and admission rates among heart failure patients with preserved ejection fraction (HF-PEF) and reduced ejection fraction (HF-REF) in Sweden | ||||
Wikstrom G1, Stalhammar J2, Ariely R3, Linder R4, Ogbonnaya A5, Stern L5 | ||||
1Uppsala University, Department of Medical Sciences, Cardiology, Uppsala, Sweden, 2Uppsala University, Department of Public Health and Caring Sciences, Uppsala,Sweden, 3Novartis Pharmaceuticals Corporation,East Hanover,USA, 4IMS Health,(Formally Pygargus AB)Stockholm, Sweden, 5Analytica International, New York, USA | ||||
European Heart Failure Congress, Gothenbourg, May 21-24, 2011 |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: http://spo.escardio.org/Abstract.aspx?eevtid=46&fp=P1289 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2011 | English | , Retrospective cohort analysis, Retrospective database analysis | |
Mortality and admission rates among heart failure (HF) patients with preserved ejection fraction (HF-PEF) and reduced ejection fraction (HF-REF) in Sweden | ||||
Wikstrom G, Stalhammar J, Ariely R, Linder R, Ogbonnaya A, Stern L | ||||
Uppsala University, Department of Medical Sciences, Cardiology - Uppsala - Sweden | ||||
European Journal of Heart Failure Supplements (2011) 10 ( S1 ), S251 |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: https://spo.escardio.org/SessionDetails.aspx?eevtid=46&sessId=7810&subSessId=1138&searchQuery=%2fdefault.aspx%3feevtid%3d46%26days%3d%26topics%3d%26types%3d%26rooms%3d%26freetext%3dAriely%26sort%3d1%26page%3d1%26showResults%3dTrue%26nbPerPage%3d20%26WithWebcast%3d%26WithSlides%3d%26WithAbstract%3d%26WithReport%3d | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2011 | English | , Retrospective database analysis | |
Healthcare encounters among heart failure (HF) patients with preserved ejection fraction (HF-PEF) and reduced ejection fraction (HF-REF) in Sweden | ||||
Wikstrom G, Stalhammar J, Ariely R, Linder R, Ogbonnaya A, Stern L | ||||
Uppsala University, Department of Medical Sciences, Cardiology - Uppsala - Sweden | ||||
European Journal of Heart Failure Supplements (2011) 10 ( S1 ), S92 |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Abstract: https://spo.escardio.org/SessionDetails.aspx?eevtid=46&sessId=7804&subSessId=1013&searchQuery=%2fdefault.aspx%3feevtid%3d46%26days%3d%26topics%3d%26types%3d%26rooms%3d%26freetext%3dAriely%26sort%3d1%26page%3d1%26showResults%3dTrue%26nbPerPage%3d20%26WithWebcast%3d%26WithSlides%3d%26WithAbstract%3d%26WithReport%3d | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2011 | English | , Retrospective database analysis | |
Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in Sweden. | ||||
Valentine WJ1, Aagren M2, Haglund M3-4, Ericsson A3, Gschwend MH5 | ||||
1Ossian Health Economics and Communication, Basel, Switzerland, 2Novo Nordisk Inc., Princeton, NJ, USA, 3Novo Nordisk Scandinavia AB, Malmo, Sweden, 4NeuroSearch A/S, Ballerup, Denmark and 5IMS Health, Basel, Switzerland | ||||
Scandinavian journal of public health |
||||
, Manuscript in preparation | ||||
, Nordic, Switzerland | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20688795 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2011 | English | , Cost effectiveness | |
Prevalence of affective disorders in South-West region of Sweden. | ||||
Löfroth E, Myrén KJ, Bruce S, Dahlberg E. | ||||
IMS Health, Stockholm, Sweden. | ||||
ISPOR 13th Annual European Congress, 2010, 6-9 November, Prague, Czech Republic |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Abstract: http://www.ispor.org/congresses/Prague1110/posters3.aspx | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2010 | English | , Retrospective database analysis | |
Atomoxetine's effect on societal costs in Sweden | ||||
Myrén KJ, Thernlund G, Nylén A, Schacht A, Svanborg P | ||||
IMS Health Sweden AB. | ||||
J Atten Disord. 2010 May;13(6):618-28. Epub 2009 Apr 13 |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=%22journal+of+attention+disorders%22%5BJour%5D+AND+13%5Bvolume%5D+AND+618%5Bpage%5D+AND+2010%5Bpdat%5D&cmd=detailssearch | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2010 | English | , Burden of illness | |
Cost-effectiveness of tapentadol prolonged-release (PR) compared to oxycodone and morphine in patients with chronic moderate to severe non-cancer pain in Sweden | ||||
Hertel N1, Ikenberg R1, Fricke FU12, Liedgens H3 | ||||
1IMS Health, Nuremberg, Germany 2Georg Simon Ohm University of Applied Sciences, Nuremberg, Germany 3Gruenenthal GmbH, Aachen, Germany | ||||
ISPOR November 6-9, 2010 Prague, Czech Republic |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Musculoskeletal disease | 2010 | English | , Cost benefit | |
Cost effectiveness of darunavir/ritonavir 600/100 mg bid in treatment-experienced, lopinavir-naive, protease inhibitor-resistant, HIV-infected adults in Belgium, Italy, Sweden and the UK. | ||||
Moeremans K1, Hemmett L2, Hjelmgren J3, Allegri G4, Smets E5 | ||||
1 IMS Health, Brussels, Belgium 2 Tibotec, Buckinghamshire, UK 3 Janssen-Cilag AB, Stockholm, Sweden 4 Janssen-Cilag SpA, Cologno Monzese, Italy 5 Johnson & Johnson Pharmaceutical Services LLC, Mechelen, Belgium | ||||
Pharmacoeconomics, 2010, 28 (Suppl 1): 147-167 |
||||
, Article | ||||
, Belgium, Italy, Nordic, Sweden, UK | ||||
Condition | Year | Language | Analysis type | |
, HIV AIDS | 2010 | English | , Cost effectiveness | |
Daily costs of Prostaglandin analogues as monotherapy or in fixed combinations with Timolol, in Denmark, Finland, Germany and Sweden | ||||
Bergstrom A1, Maurel F2, Le Pen C3, Lamure E2, Kent M4, Bardoulat I2,Berdeaux GH5,6 | ||||
1 Lund Hospital, Lund, Sweden 2 IMS France, Puteaux, France 3 Université Paris-Dauphine, Paris, France 4 Alcon Inc, Fort Worth, Texas, USA 5 Alcon France SA, Rueil-Malmaison, France 6Conservatoire National des Arts et Métiers, Paris, France | ||||
Clin Ophthalmol. 2009;3:471-81 |
||||
, Article | ||||
, Denmark, Finland, Germany, Nordic, Sweden | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732058/?tool=pubmed | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2009 | English | , Economic evaluation | |
Cost-effectiveness of etravirine in Sweden in treatment-experienced HIV-1-infected adults with evidence of NNRTI resistance and ? 3 PI mutations. | ||||
Moeremans K1, Hjelmgren J2, Martin S3 | ||||
1 IMS Health, Brussels, Belgium 2 Janssen-Cilag, Birkeöd, Denmark 3 J&J, Mechelen, Belgium | ||||
12th European Aids Conference, 2009, November 11-14, Cologne, Germany ISPOR 12th Annual European Congress, 2009, October 24-27, Paris, France |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Condition | Year | Language | Analysis type | |
, HIV AIDS | 2009 | English | , Cost utility | |
The impact of acute myocardial infarction and stroke on health care costs in patients with type 2 diabetes in Sweden. | ||||
Ringborg A, Yin DD, Martinell M, Stålhammar J, Lindgren P. | ||||
IMS Health, Stockholm. (Formally Pygargus) | ||||
Eur J Cardiovasc Prev Rehabil. 2009 Oct;16(5):576-82. doi: 10.1097/HJR.0b013e32832d193b. |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=The+impact+of+acute+myocardial+infarction+and+stroke+on+health+care+costs+in+patients+with+type+2+diabetes+in+Sweden&TransSchema=title&cmd=detailssearch | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2009 | English | , Burden of illness, Cost of illness | |
Antidepressant use and mortality in Finland: a register-linkage study from a nationwide cohort | ||||
Haukka J, Arffman M, Partonen T, Sihvo S, Elovainio M, Tiihonen J, Lönnqvist J, Keskimäki I | ||||
National Institute for Health and Welfare, Helsinki, Finland | ||||
European Journal of Clinical Pharmacology (2009); 65(7):715-20 |
||||
, Article | ||||
, Finland, Nordic | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2009 | English | , Epidemiological study, Population Based Study, Retrospective database analysis | |
Long-term cost-effectiveness of insulin detemir compared to neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal?bolus regimen in Sweden. | ||||
Valentine WJ1, Lammert M2, Aagren M3, Gschwend M1. | ||||
1 IMS Health, Basel, Switzerland; 2 Novo Nordisk Scandinavia AB, Copenhagen, Denmark; 3 Novo Nordisk, Bagsværd, Denmark | ||||
ISPOR 2008 13th Annual International Congress |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Cost effectiveness | |
Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data. | ||||
Ringborg A, Martinell M, Stålhammar J, Yin DD, Lindgren P. | ||||
IMS Health, Stockholm. (Formally Pygargus) | ||||
Int J Clin Pract. 2008 May;62(5):708-16. doi: 10.1111/j.1742-1241.2008.01716.x. Epub 2008 Mar 17. |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Resource+use+and+costs+of+type+2+diabetes+in+Sweden+%E2%80%93+estimates+from+population-based+register+data&TransSchema=title&cmd=detailssearch | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Cost consequence, Cost of illness | |
Evaluating the clinical effects and the cost-effectiveness of prophylactic cervical cancer vaccination within an organised population-based screening setting ? case Finland | ||||
Saku Torvinen, Pekka Nieminen, Nadia Demarteau, Susanne Bergius, Jarmo Hahl | ||||
ISPOR 2007 10th Annual European Congress |
||||
, Finland, Nordic | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Cost effectiveness | |
Adaptation of a health economic model of the natural history of HPV infection and cervical cancer in a well functioning population-based screening system ? a model calibration to Finland | ||||
Saku Torvinen, Pekka Nieminen, Nadia Demarteau, Susanne Bergius, Jarmo Hahl | ||||
ISPOR 2007 10th Annual European Congress |
||||
, Finland, Nordic | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | ||
Long-term clinical and economic outcomes for patients with type 1 diabetes treated with insulin aspart versus human soluble insulin in Sweden | ||||
Tucker D1, Brandt AS2, Foos V1, Munro V3, Goodall G1, Ray J1,Valentine WJ1, Roze S1, Palmer AJ1 | ||||
1 1 CORE?Center for Outcomes Research, A Unit of IMS, Allschwil, Basel, Switzerland, 2 Novo Nordisk Scandinavia AB, Malmo, Sweden, 3 Novo Nordisk Ltd, Crawley, West Sussex, UK | ||||
Value in Health, Vol. 9, Issue 6, A226–A227 |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2006 | English | , Economic evaluation | |